Syncom Formul.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE312C01025
  • NSEID: SYNCOMF
  • BSEID: 524470
INR
14.02
-0.19 (-1.34%)
BSENSE

Jun 18

BSE+NSE Vol: 15.41 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "14.02",
    "chg": -0.19,
    "chgp": "-1.34%",
    "dir": -1,
    "prev_price": "14.21",
    "mcapval": "1,328.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE312C01025",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "15.41 lacs",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswaluat.com/MOSL-Landingstocks-analysis/syncom-formul-831770-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [],
    "total": 1,
    "sid": "831770",
    "stock_news_url": "https://marketsmojo.motilaloswaluat.com/news/syncom-formulations-india-831770"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "23-May-2026",
      "details": "Submission of Press Clipping related to extract of Audited Financial Results for the year ended 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2026.",
      "datetime": "22-May-2026",
      "details": "Pursuant to regulation 33(3)(d) of SEBI LODR Regulations 2015 we are pleased to submit the financials for the year ended on 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2026",
      "datetime": "22-May-2026",
      "details": "Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations 2015 we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors Report thereon by Statutory Auditors Statement of Assets and Liabilities and Cash Flow for the quarter/year ended on 31st March 2026 in PDF Format which were approved by the Audit Committee and Board of Directors at their meeting held on Friday 22nd May 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>3%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

23-May-2026 | Source : BSE

Submission of Press Clipping related to extract of Audited Financial Results for the year ended 31.03.2026

Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2026.

22-May-2026 | Source : BSE

Pursuant to regulation 33(3)(d) of SEBI LODR Regulations 2015 we are pleased to submit the financials for the year ended on 31st March 2026

Board Meeting Outcome for Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2026

22-May-2026 | Source : BSE

Pursuant to Regulation 33(3)(d) of SEBI (LODR) Regulations 2015 we are pleased to submit the Standalone & Consolidated Audited Financial Results along with Auditors Report thereon by Statutory Auditors Statement of Assets and Liabilities and Cash Flow for the quarter/year ended on 31st March 2026 in PDF Format which were approved by the Audit Committee and Board of Directors at their meeting held on Friday 22nd May 2026.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Syncom Formulations (India) Ltd has declared 3% dividend, ex-date: 09 Sep 22

stock-summary
SPLITS

Syncom Formulations (India) Ltd has announced 1:10 stock split, ex-date: 19 Aug 13

stock-summary
BONUS

Syncom Formulations (India) Ltd has announced 5:2 bonus issue, ex-date: 19 Aug 13

stock-summary
RIGHTS

Syncom Formulations (India) Ltd has announced 1:2 rights issue, ex-date: 13 May 09